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Abstract 
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging clinical entity with its 
propensity for recurrence. This disease decreases the patients’ quality of life and creates a high economic burden. 
An effort to investigate the aetiology of recurrent polyps have to be more alert. 
AIM: This study aims to prove the differences in expression of IL-5, IL-8, IL-17A and TGF-β1 in mucosal and 
polyp tissue between CRSwNP and recurrent CRSwNP and also to determine which expression of cytokines that 
have the main role in mucosal and polyp tissue in recurrent CRSwNP. 
MATERIAL AND METHODS: An observational study was conducted with a comparative cross-sectional design 
of CRS patients with 15 recurrent CRSwNP and CRSwNP who had never undergone surgery for as many as 15 
polyps. Mucosal specimens of nasal polyps are taken by brushing, and polyp tissue specimens are taken during 
surgical removal of nasal polyps. Specimens from the polyp mucosa were examined by ELISA while the polyp 
tissue specimens were carried out immunohistochemistry (IHC). 
RESULTS: The result showed that there is a significant difference in IL-5 expression in the polyp mucosal 
between CRSwNP with recurrent CRSwNP, where expression is higher in recurrent CRSwNP. The expression of 
IL-8, IL-17 and TGF-β1 were lower in recurrent CRSwNP, but the difference was not significant. In nasal polyp 
tissue, there is a significant difference in TGF-β1 and IL-8 expression between CRSwNP and recurrent CRSwNP, 
where the expression of both cytokines is lower in recurrent CRSwNP. Interleukin-5 expression was higher in 
recurrent CRSwNP than CRSwNP, but the difference was not significant. In the polyps mucosal, IL-5 has the 
main role in recurrent CRSwNP polyp, whereas TGF-β has the main role in polyp tissue.  
CONCLUSION: This study concluded that the expression of IL-5 in the mucosa could be examined with simple 
techniques like brushing before polypectomy or FESS was performed to determine the possibility of polyps 
recurrencies. 
 
 
 
 
 
Introduction 
 
Chronic rhinosinusitis (CRS) is one of the 
chronic diseases that is often encountered in the 
community. This disease decreases the quality of life 
of patients, besides causing economic burdens due to 
the high cost of treatment [1], [2], [3]. Rinia et al. 
(2007) stated that the prevalence of nasal polyps in 
the general population reached 0.5-4.3%. Therefore 
polyps become one of the most common cases in 
chronic upper respiratory tract infections [4]. The 
prevalence of chronic rhinosinusitis in Europe reaches 
19.7% [2]. Rhinosinusitis with polyps often recurrence. 
Polyps often grow back after surgery, so patients have 
to experience repeated surgeries. According to 
Kosem et al., (2010), the rate of recurrence in nasal 
polyps reaches 10% [5]. Until now, there has been no 
benchmark for predicting cases that will experience 
recurrence after polypectomy [6]. 
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Some factors that are thought to underlie the 
occurrence of nasal polyps are genetic factors, 
allergic factors, irritants and pollutants, the role of 
bacterial and fungal infections, and anatomical 
variations in the lateral nasal wall and local 
immunological balance disorders that cause chronic 
inflammation [2]. The differences in inflammatory 
patterns in CRS with polyps (CRSwNP) are, the 
eosinophilic Th2 inflammation pattern is commonly 
found in Caucasian races while neutrophilic Th1/Th17 
inflammation pattern is found in Asian races [1], [7]. 
Various factors involved in the pathogenesis 
of CRSwNP make it challenging in determining the 
immunological phenotype and management of CRS 
with polyps where the tendency for recurrence is high. 
The difficulties in identifying trends in recurrence of 
CRSwNP occurred due to complex problems and the 
number of factors involved in CRSwNP. It is 
necessary to look for markers to be used as predictors 
in monitoring the possibility of CRSwNP being 
recurrent and efforts to find methods that are easy 
and not invasive for taking nasal polyp specimens. 
This study aimed to prove the differences in 
expression of IL-5, IL-8, IL-17A and TGF-β1 in 
mucosal and polyp tissue between CRSwNP and 
recurrent CRSwNP and also to determine which 
expression of cytokines that have the main role in 
mucosal and polyp tissue in recurrent CRSwNP. 
 
 
Material and Methods 
 
Sample 
Samples were obtained from CRSwNP 
patients who visited the Ear, Nose and Throat (ENT) 
clinic in the Public Central Hospital Dr M Djamil 
Padang and several hospitals in West Sumatera on 
August 2016 until September 2018. There was 15 
patient CRSwNP dan 15 patient with recurrent 
CRSwNP. Before the study, approval of the study was 
asked of respondents before the operation. Samples 
were taken from CRSwNP patients aged 18 to 55 
years who did not use anti-allergic drugs during the 
washout period before brushing (chlorpheniramine 3 
days, cetirizine, fexofenadine, loratadine, respectively 
5 days and 2 weeks for corticosteroids). 
 
Sampling 
Brushing was performed on nasal polyps 
mucosa with the nasoendoscopy in a circular motion 
by using a modified gynecologic cytology brush. 
Before brushing the polyp, a cotton tampon containing 
lidocaine and adrenaline installed with a ratio of 4:1 
for 10 minutes on the nasal cavity. Brushing was done 
on the mucosa of the polyp in a circular motion ten 
times clockwise. Samples obtained from brushing 
were inserted into a sterile bottle containing PBS 
liquid and immediately taken to the Biomedical 
laboratory in the Faculty of Medicine, Andalas 
University and stored at a temperature of -80°C. 
Retrieval of nasal polyp tissue is performed 
during surgical removal of the polyp by FESS 
(Functional Endoscopy Sinus Surgery). When FESS 
was performed, polyp tissue samples were put into 
neutral formalin liquid and immediately taken to the 
Anatomy Pathology Laboratory of the Andalas 
University Medical School to make paraffin blocks.  
 
ELISA 
In this research, human IL-5, IL-17 and TGF-
β1 were used from R&D and human IL-8 from BT lab 
to examining nasal mucous polyps. 
 
IHC 
Immunohistochemical staining techniques 
using the Labeled Streptavidin-Biotin Complex (LSAB) 
method were carried out by manual procedure. The 
staining results of the preparations were measured 
and calculated using a microscope to assess the 
expression of IL-5, IL-8, IL-17, and TGF- β1. Positive 
values are the results of assessments of the brown 
intensity of epithelium and stroma seen in the light 
microscope. 
 
Statistical Analysis 
We use SPSS program version 17.0.0.0.  
 
 
Results 
 
Characteristic 
In this study, the percentage of males in 
recurrent CRSwNP was higher than CRSwNP, which 
was 80%:66.7%, while the percentage of female in 
CRSwNP was higher than recurrent CRSwNP at 
33.3%:20% and statistically the difference was not 
significant (p > 0.05). The percentage of the male is 
higher than female, which is 66.7%:33.3% in 
CRSwNP and 80%:20% in recurrent CRSwNP. The 
mean age was higher in the recurrent CRSwNP group 
(41.40 ± 10.23 years) than in the CRSwNP (36.20 ± 
11.61 years) and was not significant (p > 0.05). 
Table 1: Characteristics of respondents based on gender and 
age 
Characteristics CRSwNP (n = 15) recurrent CRSwNP (n = 15) p 
Sex 
Male 
 
10 (66.7 %) 
 
12 (80%) 
 
0.682 
Female 5 (33.3 %) 3 (20%)  
Age 36.20 ± 11.61 41.40 ± 10.23 0.204 
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In this study, the mean mucosal IL-5 
expression was higher in recurrent CRSwNP (2.75 ± 
2.02) than CRSwNP (0.86 ± 0.13), and a statistically 
significant difference was found (p < 0.05). The mean 
interleukin-8 mucosal expression was higher in 
CRSwNP (327.51 ± 33.16) than recurrent CRSwNP 
(304.35 ± 34.86), but the difference was not 
statistically significant (p > 0.05). Similar to IL-8, the 
mean IL-17 expression in the CRSwNP mucosa 
(26.56 ± 22.07) is higher than the recurrent CRSwNP 
(20.13 ± 16.78), and statistically, the difference was 
not significant between CRSwNP and recurrent 
CRSwNP (p > 0.05). The mean TGF-β1 expression in 
the polyps mucosa was also higher in CRSwNP 
(32.40 ± 33.84) than recurrent CRSwNP (24.51 ± 
17.03), and the difference was also not significant 
between the two groups (p > 0.05) (Table 2). 
Table 2: Expression of IL-5, IL-8, IL-17, and TGF-β1 in mucosa 
between CRSwNP and recurrent CRSwNP 
Cytokine n CRSwNP recurrent CRSwNP p 
Mean ± SD (pg/dl) Mean ± SD (pg/dl) 
IL-5 15 0.86 ± 0.13 2.75 ± 2.02 0.003 
IL-8 15 327.51 ± 33.16 304.35 ± 34.86 0.073 
IL-17 15 26.56 ± 22.07 20.13 ± 16.78 0.418 
TGF-β1 15 32.40 ± 33.84 24.51 ± 17.03 0.427 
 
In Table 3, the mean of IL-5 expression in 
polyp tissue was higher in recurrent CRSwNP (78.80 
± 15.01) than CRSwNP (63.46 ± 27.28), and the 
difference was not statistically significant (p > 0.05). 
The mean of IL-8 expression in polyp tissue was 
found higher in CRSwNP 90.20 ± 14.78) than 
recurrent CRSwNP (78.33 ± 18.79) and there were 
significant differences between the two groups (p > 
0.05).  
Table 3: Differences in the expression of IL-5 IL-8, IL-17, and 
TGF- β1 tissue between CRSwNP with recurrent CRSwNP 
Cytokine n CRSwNP recurrent CRSwNP p 
Mean ± SD (per 100 cells) Mean ± SD (per 100 cells) 
IL-5 15 63.46 ± 27.28 78.80 ± 15.01 0.067 
IL-8 15 90.20 ± 14.78 78.33 ± 18.79 0.014 
IL-17 15 89.40 ± 16.48 77.13 ± 29.64 0.274 
TGF-β1 15 93.66 ± 7.37 85.33 ± 12.38 0.035 
 
The mean of IL-17 expression in CRSwNP 
tissue (89.40 ± 16.48) was also higher than recurrent 
CRSwNP (77.13 ± 29.64) but did not have a 
significant difference between the two groups (p > 
0,05). On tissue, similar to IL-8, the mean TGF-β1 
expression was higher in CRSwNP (93.66 ± 7.37) 
than recurrent CRSwNP (85.33 ± 12.38) and also 
there were significant differences between CRSwNP 
and recurrent CRSwNP (p > 0.05). 
Table 4: Multivariate cytokine test on the mucosa of recurrent 
CRSwNP 
Cytokine P Exp(B) 
Step 1 
IL-5 
IL-8 
IL-17 
TGF-β1 
 
0.051 
0.091 
0.423 
0.284 
 
0.000 
1.046 
1.042 
1.032 
Step 2 
IL-5 
IL-8 
TGF-β1 
 
0.040 
0.102 
0.226 
 
0.000 
1.044 
1.044 
Cytokines that have the most role in 
 recurrent CRSwNP 
The results of the mucosal analysis found that 
the cytokine that had the main role in the polyps 
mucosa in the recurrent CRSwNP was IL-5 (Table 4). 
Whereas in tissues, based on the analysis, TGF-β1 
was the main role in polyp tissue in recurrent 
CRSwNP was (Table 5). 
Table 5: The multivariate cytokine test on the tissue of 
recurrent CRSwNP 
Cytokine P Exp (B) 
Step 1 
IL-5 
IL-8 
IL-17 
TGF-β1 
 
0.143 
0.072 
0.819 
0.104 
 
0.964 
1.060 
0.994 
1.097 
Step 2 
IL-5 
IL-8 
TGF-β1 
 
0.136 
0.061 
0.102 
 
0.966 
1.057 
1.097 
Step 3 
IL-8 
TGF-β1 
 
0.073 
0.054 
 
1.048 
1.106 
 
 
 
Discussion 
 
In this study, specimens were taken from 
mucosal in recurrent CRSwNP and CRSwNP polyps 
using the brushing technique. In these specimens, 
cytokine IL-5, IL-8, IL-17 and TGF-β1 expression were 
examined by ELISA technique. It was found that only 
IL-5 expression had a significant difference between 
the mucosal CRSwNP recurrent and CRSwNP (p < 
0.05). Polyp tissue specimens were taken during 
surgical removal of polyps with the FESS technique, 
and then the IHC examination was carried out.  
 
Figure 1: Description of cell expression that produces cytokines in 
CRSwNP tissue with 40 X 10 enlargement: a) description of IL-5 
expression; b) description of IL-8 expression; c) description of IL-17 
expression; d) description of TGF-β1 expression. Red arrows 
indicate cells that contained positive cytokines 
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 The results showed that only TGF-β1 and IL-8 
had significant differences (p < 0.05) between 
CRSwNP and CRSwNP recurrent; both expressions 
were lower in recurrent CRSwNP than CRSwNP. 
 
Figure 2: Description of cell expression that produces cytokines in 
recurrent CRSwNP tissue with 40X10 enlargement: a) description of 
IL-5 expression; b) description of IL-8 expression; c) description of 
IL-17 expression; d) description of TGF-β1 expression. Red arrows 
indicate cells that contained positive cytokines 
 
Expression of IL-5 was found to be higher in 
mucosal CRSwNP recurrent (2.75 ± 2.02) than 
CRSwNP (0.86 ± 0.13) and statistically significant 
differences (p < 0.05). In polyp tissue, IL-5 expression 
in CRSwNP recurrent (78.8 ± 15.01) was also higher 
than CRSwNP (63.46 ± 27.28). Interleukin-5 is a 
cytokine that plays an important role in the 
differentiation, development, maturation and 
chemokine processes of eosinophils [8]. One study 
state that IL-5 and Eosinophil Cationic protein (ECP) 
is eosinophilic type inflammatory biomarkers that can 
be used as predictors and diagnostics in the future [9]. 
Research on the relationship of IL-5 and eosinophils 
with recurrence of nasal polyps has been carried out. 
Wei et al., (2018) conducted a multivariate analysis of 
recurrent CRSwNP in China obtaining IL-5 expression 
in polyp tissue as well as higher recurrence of 
CRSwNP than non-recurrent polyp CRS and was 
statistically significant (p = 0.001) [10]. Van Zele et al., 
(2014) obtained IL-5 expression which was also 
higher in recurrent CRSwNP (482.8pg/ml) than non-
recurrent polyp CRS (144.7 pg/ml) and was 
statistically significant (p < 0.05). Based on their 
studies, it was found that the type of Th2 inflammation 
and eosinophilic inflammation were the main risk 
factors for recurrence [1]. In another study also 
reported that eosinophil counts by histopathological 
examination could be used as an easy method to do 
as a predictor of postoperative nasal polyps 
recurrence [11]. In this study, the expression of tissue 
IL-5 in recurrent CRSwNP was higher than CRSwNP 
because IL-5 is a cytokine that plays an important role 
in the differentiation, development, maturation and 
chemokines of eosinophils where eosinophils are 
closely related to the recurrence of nasal polyps. 
This study found that the mean mucosal IL-8 
expression was higher in CRSwNP (327.51 ± 33.16) 
than recurrent CRSwNP (304.35 ± 34.86), but the 
differences in IL-8 expression were not statistically 
significant (p > 0.05). In the polyp tissue, it was also 
found that the mean IL-8 expression was higher in 
CRSwNP (90.20 ± 14.78) than in the recurrent 
CRSwNP (78.33 ± 18.79) and had a significant 
relationship (p < 0.05).In another study conducted by 
Wei et al., (2018) it was found that the mean IL-8 was 
also higher in CRSwNP (5080.1 pg/ml) than recurrent 
CRSwNP (2481.9 pg/ml) and was statistically 
significant [10]. Interleukin-8 is produced by 
monocytes, lymphocytes, endothelial granulocytes. 
Interleukin-8 is an inflammatory cytokine that has 
strong neutrophil chemotaxis activity and can induce 
degranulation, respiratory burst, adherence, 
deformation, Ca2+ mobilisation and increased 
regulation of neutrophils CD11b/CD18 [12]. 
Interleukin-8 will stimulate deformation and 
degranulation of neutrophils, thus releasing elastase, 
lactoferrin, fibronectin. Also, IL-8 can stimulate 
transendothelial neutrophil migration by increasing 
regulation of α2 integrins [13]. In addition to 
neutrophils, IL-8 is also a very important chemokine 
for eosinophils in all types of CRS and nasal polyps. 
Interleukin-8 is secreted by the ductal cells of the 
glandular and epithelial cells, attracting neutrophils to 
the mucosa [14], [15]. In this study, IL-8 expression in 
CRSwNP was higher than recurrent CRSwNP, and 
the difference was significant because IL-8 is a 
neutrophilic chemoactrant while recurrent CRSwNP is 
more identical to eosinophilic polyps. 
The results of the ELISA examination of the 
polyp mucosa in this study obtained an average 
Interleukin-17 expression in CRSwNP (26.56 ± 22.07) 
was higher than the recurrent CRSwNP (20,13 ± 
16,78), and the difference was not significant (p = 
0.41). In nasal polyp tissue, the mean IL-17 
expression was also higher in CRSwNP (89.40 ± 
16.48) than recurrent CRSwNP (77.13 ± 29.64). Van 
Zele et al. (2014) conducted a cohort study comparing 
the expression of IL-17 between non-recurrent 
CRSwNP and recurrent CRSwNP. The results 
showed that IL-17 expression in CRSwNP was also 
higher than recurrent CRSwNP, and there were no 
significant differences between the two groups (p = 
0.202). Van Zele et al., (2014) explained that induction 
of IL-17 is associated with a decreasing in the 
expression of IL-5 and ECP which means that it 
decreases eosinophilic inflammation while IL-17 can 
modulate life and prolong neutrophil life by decreasing 
neutrophil apoptosis. Th17 cells through IL-17 induce 
secretion of IL-6 and IL-8 in fibroblast, endothelial and 
epithelial cells (1). Jiang et al., (2011) also reported 
that there were no significant differences in 
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expression of IL- 17 between CRSwNP type 
eosinophilic and non-eosinophilic (p > 0.05) and found 
that IL-17 affected the growth of nasal polyps with 
thickening of lamina basal cells and glandular 
hyperplasia [16]. Wei et al., (2018), in their study, also 
found there was no significant difference in IL-17 
expression between CRSwNP and recurrent 
CRSwNP [10]. In this study, it can be concluded that 
IL-17 has no effect on the recurrence of CRSwNP but 
affects the growth of nasal polyps by extending the life 
of neutrophils, thickening of lamina basal cells and 
glandular hyperplasia. 
On the polyps mucosa, the mean TGF-β1 
expression was also higher in CRSwNP (32.40 ± 
33.84) than in recurrent CRSwNP (24.51 ± 17.03), 
and there were no significant differences between 
these two group (p > 0,05). Transforming Growth 
Factor-β1 expression was higher in CRSwNP (93.66 ± 
7.37) than recurrent CRSwNP (85.33 ± 12.38) in nasal 
polyp tissue, and there were statistically significant 
differences between the two groups (p < 0.05). 
Transforming Growth Factor Beta1 is a mediator 
associated with tissue remodelling. Physiologically 
TGF-β1 is a counter-regulatory cytokine against 
inflammation and initiates the process of repair and 
formation of fibrosis [17]. Transforming Growth Factor 
Beta1 is the main regulator of the immune system as 
a basic role in the production and secretion of the 
extra cellular matrix (ECM) and fibrosis molecules 
[18]. Other theories speculate that TGF-β1 reduce the 
effects of the proliferation of growth factors, such as 
platelet-derived growth factor (PDGF) and vascular 
endothelial growth factor (VEGF), which controls the 
proliferation of epithelial cells of nasal polyps, so that 
reduced the expression of TGF-β1 or inactivation of 
receptors of TGF-β1, therefore can explain the 
hyperproliferation abnormalities [19]. Van Zele 
reported there was no significant difference in TGF-β1 
expression between recurrent and non-recurrent 
polyps. This explains that remodelling factors only 
have a role at the beginning of the development of 
nasal polyps but subsequently do not affect the 
occurrence of recurrence and prognosis of the 
disease [1]. In this study, it was found that TGF-β1 
tissue expression in recurrent CRSwNP was lower 
than CRSwNP, and the difference was statistically 
significant. It is explained there is an imbalance 
between fibrinolysis and fibrinogenesis, reduced effect 
of proliferative inhibition by TGF-β1 so that the lower 
expression of TGF-β1 in tissues can predict 
recurrence in nasal polyps. 
 Based on the results of multivariate analysis, 
it was found that the cytokine had the main role in 
CRS polyp recurrence on the ELISA examination 
taken from the mucosal polyp was IL-5 (p < 0.05), 
whereas from the IHC examination was TGF-β1. In 
the mucosa, the cytokine that has the main role in 
recurrence is IL-5, where IL-5 is an interleukin that is 
important for the differentiation, maturation and 
survival of eosinophils. The increasing of IL-5 shows a 
predominant T helper 2 (Th2) response, which 
increases infiltration of inflammatory cells, especially 
eosinophil [20]. Lou (2018), reported that IL-5 is an 
eosinophilic type of inflammatory biomarker that can 
be used as a predictor and diagnostics in the future 
[9]. Eosinophilic inflammation in CRS polyp has been 
widely studied as a positive predictor of nasal polyps 
recurrence [15], [21], [22], [23].  
Thus, it can be concluded that the 
examination of the expression of IL-5 in the mucosa 
with simple techniques such as brushing in this study 
before polypectomy or FESS in CRSwNP can be used 
to determine the possibility of polyps currencies.  
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